Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Vermersch

Showing results (161-170 of 250) with videos related to

Pageof 25
Sort By:
Journal of Neuroimmunology|August 9, 2006
Diversified serum IgG response involving non-myelin CNS proteins during experimental autoimmune encephalomyelitisHelene Zephir, Lionel Almeras, Mohamed El Behi, et al.
Radiology|October 6, 2015
Asymptomatic Progressive Multifocal Leukoencephalopathy Associated with Natalizumab: Diagnostic Precision with MR ImagingJérôme Hodel, Olivier Outteryck, Céline Dubron, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 10, 2020
Long-term effect of natalizumab in patients with RRMS: TYSTEN cohortKévin Bigaut, Thibaut Fabacher, Laurent Kremer, et al.
European Journal of Neurology|June 8, 2026
Progression to Wheelchair in Secondary Progressive Multiple Sclerosis and Impact of Siponimod: Post Hoc Analyses From the EXPAND StudyPatrick Vermersch, Sophie Arnould, Ralf Gold, et al.
European Journal of Neurology|April 15, 2025
Generics, Biosimilars and Follow-On Non-Biologic Complex Drugs for Multiple Sclerosis: A Narrative Review of the Regulatory and Clinical Implications for European NeurologistsThomas Berger, Markus Zeitlinger, Veronica Popescu, et al.
Journal of Neurology|April 25, 2012
Anti-JCV antibody prevalence in a French cohort of MS patients under natalizumab therapyOlivier Outteryck, Jean-Claude Ongagna, Alain Duhamel, et al.
Journal of the Neurological Sciences|October 10, 2009
Effective immune restoration after immunosuppressant discontinuation in a lupus patient presenting progressive multifocal leukoencephalopathyGuillaume Lefèvre, Viviane Queyrel, Claude-Alain Maurage, et al.
The Lancet. Neurology|August 21, 2021
Safety and efficacy of tolebrutinib, an oral brain-penetrant BTK inhibitor, in relapsing multiple sclerosis: a phase 2b, randomised, double-blind, placebo-controlled trialDaniel S Reich, Douglas L Arnold, Patrick Vermersch, et al.
Neurology|July 13, 2012
Methionine synthase deficiency: a rare cause of adult-onset leukoencephalopathyOlivier Outteryck, Jérôme de Sèze, Tanya Stojkovic, et al.
Neuropediatrics|August 5, 2017
Anti-HMGCR Antibody-Related Necrotizing Autoimmune Myopathy Mimicking Muscular DystrophyCéline Tard, Vincent Tiffreau, Emmanuelle Jaillette, et al.
Pageof 25

Showing results (161-170 of 250) with videos related to

Sort By:
Pageof 25
Journal of Neuroimmunology|August 9, 2006
Diversified serum IgG response involving non-myelin CNS proteins during experimental autoimmune encephalomyelitisHelene Zephir, Lionel Almeras, Mohamed El Behi, et al.
Radiology|October 6, 2015
Asymptomatic Progressive Multifocal Leukoencephalopathy Associated with Natalizumab: Diagnostic Precision with MR ImagingJérôme Hodel, Olivier Outteryck, Céline Dubron, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 10, 2020
Long-term effect of natalizumab in patients with RRMS: TYSTEN cohortKévin Bigaut, Thibaut Fabacher, Laurent Kremer, et al.
European Journal of Neurology|June 8, 2026
Progression to Wheelchair in Secondary Progressive Multiple Sclerosis and Impact of Siponimod: Post Hoc Analyses From the EXPAND StudyPatrick Vermersch, Sophie Arnould, Ralf Gold, et al.
European Journal of Neurology|April 15, 2025
Generics, Biosimilars and Follow-On Non-Biologic Complex Drugs for Multiple Sclerosis: A Narrative Review of the Regulatory and Clinical Implications for European NeurologistsThomas Berger, Markus Zeitlinger, Veronica Popescu, et al.
Journal of Neurology|April 25, 2012
Anti-JCV antibody prevalence in a French cohort of MS patients under natalizumab therapyOlivier Outteryck, Jean-Claude Ongagna, Alain Duhamel, et al.
Journal of the Neurological Sciences|October 10, 2009
Effective immune restoration after immunosuppressant discontinuation in a lupus patient presenting progressive multifocal leukoencephalopathyGuillaume Lefèvre, Viviane Queyrel, Claude-Alain Maurage, et al.
The Lancet. Neurology|August 21, 2021
Safety and efficacy of tolebrutinib, an oral brain-penetrant BTK inhibitor, in relapsing multiple sclerosis: a phase 2b, randomised, double-blind, placebo-controlled trialDaniel S Reich, Douglas L Arnold, Patrick Vermersch, et al.
Neurology|July 13, 2012
Methionine synthase deficiency: a rare cause of adult-onset leukoencephalopathyOlivier Outteryck, Jérôme de Sèze, Tanya Stojkovic, et al.
Neuropediatrics|August 5, 2017
Anti-HMGCR Antibody-Related Necrotizing Autoimmune Myopathy Mimicking Muscular DystrophyCéline Tard, Vincent Tiffreau, Emmanuelle Jaillette, et al.
Pageof 25